Status:
WITHDRAWN
The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?
Lead Sponsor:
Jerrry L Lewis
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether memantine will enhance the therapeutic of effect on depression and prevent memory and other cognitive problems caused by ECT.
Detailed Description
Patients will be assigned randomly either to a treatment group or a placebo groups. All patients in both groups will be receiving standard ECT. The treatment group will receive memantine. All patients...
Eligibility Criteria
Inclusion
- Meets criteria for Major Depressive disorder
Exclusion
- Neurological disease
- Mental retardation
- Seizure disorder
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00988663
Start Date
November 1 2009
End Date
November 1 2009
Last Update
March 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa hosptitals and clinic
Iowa City, Iowa, United States, 50208